CPS1 and metabolic dysfunction-associated steatotic liver disease: Conversely, CPS1 levels are elevated in the plasma of NAFLD patients with varying fibrosis extents and in the serum of individuals experiencing acetaminophen-induced acute liver failure, with levels diminishing post-injury recovery (Ajaz et al., 2021; Kwan et al., 2023).